Afya (NASDAQ:AFYA) Now Covered by Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Afya (NASDAQ:AFYA) in a research report sent to investors on Tuesday morning, MarketBeat Ratings reports. The firm issued a sell rating and a $16.00 target price on the stock.

Separately, UBS Group assumed coverage on shares of Afya in a research report on Friday, August 30th. They issued a “neutral” rating and a $19.50 price target on the stock.

Afya Price Performance

Shares of NASDAQ:AFYA opened at $15.96 on Tuesday. Afya has a 1-year low of $15.28 and a 1-year high of $22.48. The firm has a market capitalization of $1.50 billion, a PE ratio of 12.87, a PEG ratio of 0.34 and a beta of 0.89. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $16.80 and its 200-day moving average is $17.11.

Institutional Investors Weigh In On Afya

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio bought a new stake in shares of Afya during the third quarter valued at approximately $34,000. Quarry LP bought a new position in Afya in the 3rd quarter valued at $75,000. Centiva Capital LP acquired a new stake in shares of Afya in the 3rd quarter valued at $213,000. Quantbot Technologies LP raised its position in shares of Afya by 73.8% during the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after acquiring an additional 5,636 shares during the last quarter. Finally, Lifestyle Asset Management Inc. lifted its stake in shares of Afya by 26.9% during the second quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company’s stock valued at $261,000 after acquiring an additional 3,133 shares during the period. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.